Asahi Life Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,591
Closed -$357K 165
2025
Q3
$357K Buy
6,591
+1,071
+19% +$61.3K 0.2% 135
2025
Q2
$303K Buy
5,520
+140
+3% +$8.24K 0.18% 144
2025
Q1
$380K Buy
+5,380
New +$362K 0.25% 104
2024
Q4
Sell
-5,470
Closed -$384K 172
2024
Q3
$384K Buy
+5,470
New +$457K 0.23% 113
2023
Q4
Sell
-3,500
Closed -$310K 169
2023
Q3
$310K Buy
3,500
+40
+1% +$3.56K 0.11% 115
2023
Q2
$300K Buy
+3,460
New +$326K 0.1% 144
2021
Q4
Sell
-4,870
Closed -$376K 196
2021
Q3
$376K Buy
4,870
+20
+0.4% +$1.58K 0.05% 117
2021
Q2
$405K Buy
4,850
+900
+23% +$71.3K 0.05% 112
2021
Q1
$298K Buy
+3,950
New +$323K 0.04% 176

Other funds holding BMRN